Avalo Therapeutics shares surged ~60% after reporting successful Phase 2 trial results for its hidradenitis suppurativa drug today.
Super Micro Computer rose ~17% despite missing revenue targets, beating earnings and projecting FY2026 revenue $11‑$12.5 bn and EPS $0.65‑$0.79.
AMD posted Q1 EPS $1.37 and revenue $10.25 bn, both beating estimates, and raised Q2 revenue guidance to $11.2 bn.
Alphabet gained ~2% as Anthropic pledged ~$200 bn to Google Cloud over five years, while Upstart, Arista and Tempus fell 13‑11‑9% on modest guidance.